Biotech Government Legal 
Jake Jorgovan
MARCH 19, 2025
Their comprehensive approach encompasses financial, legal, operational, and strategic due diligence, ensuring that clients have a clear understanding of their potential risks and opportunities before proceeding with any transaction. Their approach is marked by a blend of technical, scientific, and commercial assessments.
Jake Jorgovan
JANUARY 24, 2024
TL;DR: Top International Tax Consultants & Consulting Firms ECOVIS : Expert in creatively navigating complex tax and legal regulations with a comprehensive, multi-disciplinary approach. ECOVIS Ecovis is a leading global consulting firm specializing in tax, auditing, accounting, and legal services in over 90 countries.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Stellar Partnerships
JUNE 4, 2023
CSL is a global biotech company and one of Australia’s biggest success stories, with profits of over $2.2bln last year. There was a big focus on the E (environmental) and there was governance around the E then although it was set under a CSR umbrella. This week we’re sharing the insights from Patrick at CSL.
Jake Jorgovan
NOVEMBER 28, 2023
Apotech Consulting: Is a trusted and dependable life science consulting organization, specializing in biotech and medtech sectors. Their services encompass a wide range of areas, including in-depth research, innovative product design and development, effective branding strategies, legal counsel, and thorough audits.
Jake Jorgovan
NOVEMBER 14, 2023
Industries: Pharma, Healthcare, Financial Services, Life-Sciences, Retail, Consumer, Media, Tech, Biotech, Cross Sector, Automotive, Aerospace & Defence, Government, B2C, B2B, Mobility, Boutique, Electric Vehicles, Federal. Industries: Civil Society, Corporate, Philanthropy, Health & Human Services, Government, Education.
Jake Jorgovan
NOVEMBER 15, 2023
With expertise in connecting organizations with top-tier executive talent, "Alliance International Services" is a trusted partner for businesses seeking CROs who can drive success in today's competitive landscape.
LaVoie Health Science Blog
JULY 1, 2020
As biotech and pharmaceutical companies work to stabilize their clinical programs and business strategies during the significant disruptions caused by the COVID-19 pandemic, one of the potential challenges that public companies may encounter is aggressive moves by activist investors looking to leverage the economic turmoil for corporate takeovers.
Expert insights. Personalized for you.
130 
Let's personalize your content